The 6th HUPO Antibody Initiative (HAI) Workshop: Sharing Data About Affinity Reagents and Other Recent Developments September 2009, Toronto, Canada

The Human Antibody Initiative (HAI) aims to promote and facilitate the use of antibodies for proteomics research. The 6th workshop for the HUPO Antibody Initiative (HAI) held in September 2009 was co‐chaired by Michael Snyder and Mathias Uhlen and discussed several aspects of antibody production, their validation, and attempts to standardise this process, in particular, when subsequently described in the literature. An update on the progress of the Human Protein Atlas was also presented to the attendees.

[1]  Peter Woollard,et al.  A Community Standard Format for the Representation of Protein Affinity Reagents* , 2009, Molecular & Cellular Proteomics.

[2]  E. Lundberg,et al.  A Genecentric Human Protein Atlas for Expression Profiles Based on Antibodies* , 2008, Molecular & Cellular Proteomics.

[3]  M. Uhlén,et al.  Antibodypedia, a Portal for Sharing Antibody and Antigen Validation Data*S , 2008, Molecular & Cellular Proteomics.

[4]  Yuchio Yanagawa,et al.  Secretagogin is a Ca2+-binding protein specifying subpopulations of telencephalic neurons , 2009, Proceedings of the National Academy of Sciences.

[5]  Katie Cottingham.  Antibodypedia seeks to answer the question: "how good is that antibody?". , 2008, Journal of proteome research.

[6]  Phil Andrews,et al.  Recommendations from the 2008 International Summit on Proteomics Data Release and Sharing Policy: the Amsterdam principles. , 2009, Journal of proteome research.

[7]  David E. Gloriam,et al.  ProteomeBinders: planning a European resource of affinity reagents for analysis of the human proteome , 2007, Nature Methods.

[8]  Mathias Uhlen,et al.  A pilot project to generate affinity reagents to human proteins , 2008, Nature Methods.

[9]  Richard M Caprioli,et al.  MALDI imaging mass spectrometry of integral membrane proteins from ocular lens and retinal tissue. , 2009, Journal of proteome research.

[10]  R. Shoemaker.  The NCI60 human tumour cell line anticancer drug screen , 2006, Nature Reviews Cancer.